A collaborative commercialization research institute, named GENTREN (GENoss + itREN) established with the supportive fund (500M/y up to 2 years) from NRF. 

Gentren started to develop and commercialize dental synthetic bone graft materials and other root canal filling materials. 

Our research and technologies initiated to become reality to the market throughout this project.

This was motivated by the transfer of two intellectural properties of Prof. Kim HW to biomaterials company (Genoss) with 100M won and 3% royalty